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Neonatal jaundice is noted in >50% of newborns [1,2]. It is more often physiological; however, sometimes serum bilirubin levels cross the normal range (as per the 
recommended guidelines by the American Academy of Paediatrics 
[AAP] [<1–2 mg/dl/4 h] [3]) to become pathological [3,4]. If 
timely detected and treated appropriately for underlying cause, 
severe consequences like bilirubin encephalopathy can be 
prevented. Severe hyperbilirubinemia warrants need for exchange 
transfusion which itself carries lot of complications. Hence, it is 
essential to understand about the science of neonatal jaundice, 
underlying causes and interventions, so as to decrease the need 
for exchange transfusion. We conducted this study to analyze the 
incidence of pathological jaundice, average time of presentation, 
possible causes of jaundice, mean duration of phototherapy, 
medical management, and need for exchange transfusion.
MATERIALS AND METHODS
This was a retrospective study conducted in a tertiary care 
hospital which included all live births who were diagnosed with 
neonatal hyperbilirubinemia requiring treatment from August 
2017 to August 2018. Exclusion criteria included any baby with 
conjugated serum bilirubin >20% of total serum bilirubin or 
>2 mg/dl or neonate with any congenital malformation.
A detailed history was recorded from patient’s files; details 
such as physical examination and blood reports were noted . 
Serum bilirubin was measured by Jendrassik and Grof method 
by fully automated analyzer. Data were also recorded at the time 
since birth for the appearance of pathological jaundice, duration 
of phototherapy, need for exchange transfusion, intravenous 
immunoglobulin, and intravenous fluid requirement.
As a protocol in our neonatal intensive care unit (NICU), all 
babies with neonatal jaundice requiring phototherapy were given 
maintenance fluids and 40% of maintenance fluids as extra to 
compensate for warmer and phototherapy losses. Maintenance 
fluids were given in the form of feeds in all babies who tolerated 
orally and the babies with neonatal hyperbilirubinemia were 
started on double surface phototherapy. All phototherapy units are 
of same quality and adjusted similarly for distance and wavelength 
(Lullaby [GE], Zeal medical; 420–470 nm wavelength).
Statistical analysis was performed in Microsoft Excel sheet 
using descriptive statistics, whereby mean and standard deviations 
were calculated for the required data.
RESULTS
The total number of live births delivered over a duration of 
13 months was 2535 (610 lower segment cesarean section 
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[LSCS] and 1925 NVD), of which 128 babies were treated for 
neonatal hyperbilirubinemia. Of 128 babies, 63 were female 
and 65 males. Among 128 neonates, 3.9% were extremely low 
birth weight (LBW), 9.3% very LBW, 14% LBW, and 72.6% 
normal birth weight and the mean birth weight was 2.93±0.47 kg. 
Nearly 33% (42/128) of babies were delivered to primigravida 
mothers. Of 128 babies, 43 (33.5%) were delivered by LSCS 
and rest 85 babies (66.4%) by vaginal route. The mean age at 
presentation in NICU for the treatment of neonatal jaundice 
was 61.5±31.3 h. Mean serum bilirubin at the time of starting 
phototherapy was 16.8±3.36 mg/dl. On evaluating the causes of 
neonatal hyperbilirubinemia, we recorded that 26.5% (34/128) 
of babies had ABO incompatibility, 12.5% (16/128) were Rh 
incompatible, 7.8% (10/128) babies showed clinical or laboratory 
evidence of sepsis, 2.3% (3/128) had cephalhematoma, and 4.6% 
(6/128) had polycythemia. No cause was found in rest 46% 
(59/128) of neonates (Fig. 1). Direct Coombs test was positive 
in four children, three being Rh incompatible and one ABO 
incompatible and the reticulocyte count (>3%) was increased in 
21 children. Of these, all babies who were neither Rh nor ABO 
incompatible were checked for deficiency of glucose-6-phosphate 
dehydrogenase (G6PD), and none of the babies were found to 
be G6PD deficient. Of 128 babies, 120 accepted oral feeds as 
maintenance fluids, rest eight babies were given maintenance 
fluids intravenously. All babies were given extra 40% of 
maintenance fluids by intravenous route. Normal saline bolus of 
20 ml/kg was given in nine babies who showed the evidence of 
dehydration, lethargy, poor feeding, decreased urine output, or 
increased capillary refilling time. Babies who had non-hemolytic 
jaundice falling near exchange range or the fall in serum bilirubin 
was less than the recommended guidelines by AAP, breastfeeds 
were replaced by formula feeds.
The mean duration of phototherapy was 32.19±20.9 h. 
Intravenous immunoglobulin was given in six children (three Rh 
incompatible, two ABO incompatible, and one sepsis) at 2 g/kg 
over 2 days. Partial exchange with normal saline was done for 
four babies, all having a hematocrit > 65% and serum bilirubin 
crossing the phototherapy range. None of the babies required 
double volume or single volume exchange transfusion. One 
baby (Rh incompatible and DCT positive) required packed cell 
transfusion.
DISCUSSION
Our study showed that nearly 5% of newborn babies developed 
neonatal hyperbilirubinemia requiring treatment. The incidence 
was comparable in males and females. We noted that the most 
common etiology isolated as the cause of jaundice was ABO 
incompatibility noted in 27% of babies. An Indian study done by 
Shetty and Kumar [2] also concluded ABO incompatibility as the 
most common cause in 13.47% cases. Similar results were shown 
by Davutoglu M et al. from Turkey [5].
An important finding noted in our study was that nearly 
46% of babies were not found to have any cause of neonatal 
hyperbilirubinemia. The study by Shetty and Kumar conducted 
in Southern India was also unable to find a cause in one-third of 
the cases, very similar to our study. After reviewing literature and 
previous studies, we found that the most likely causes for this 
group with yet unknown etiology are breastfeeding jaundice and 
genetic variability.
Breastfeeding jaundice develops in 13% of exclusively 
breastfed infants during the 1st week of life. Inadequate 
breastfeeding adds to dehydration which significantly contributes 
to increase in serum bilirubin levels. A study by Xavier et al. [1] 
showed that inadequate breastfeeding contributes to 50% of non-
physiological jaundice. According to same, aggressive lactation 
support with daily weight monitoring can reduce the requirement 
of phototherapy by 30%. The increase in serum bilirubin in 
inadequately breastfed babies is similar to increase in serum 
bilirubin seen with partial starvation in adults [6,7]. Another 
study has shown 5-fold increase in intestinal bilirubin absorption 
in newborn rhesus monkeys in spite of normal feeding [8]. 
Poor feeding leads to delay in emptying of meconium further 
adding to increased serum bilirubin levels [9]. Adequacy of 
breastfeeding can be assessed by multiple parameters [10]. 
An objective measurement is weight monitoring where body 
weight loss >7–10% in term babies by day 3 is considered as 
inadequate feeding [11]. In our study also, the mean weight at 
start of treatment was 10.3% less than the birth weight at mean 
age of 61 h, suggesting inadequate feeding. Unfortunately, a lot 
of mothers have been found to be facing feeding problems and 
require repeated lactation counseling, but the non-availability of 
counselors has added to inadequate breastfeeds in babies. Due 
to shortage of resources, daily weight monitoring could not be 
checked in babies admitted in postnatal wards. Our average 
time for presentation was 60 h which coincided with the time of 
appearance of breastfeeding jaundice. Considering breastfeeding 
jaundice as one of the most important causes in our settings, we 
gave 40% extra fluids for warmer and phototherapy losses. This 
extra fluid was meant to overcome any underlying dehydration 
and increased renal excretion of bilirubin. In patients with obvious 
features of dehydration, normal saline bolus was given. We further Figure 1: Percentage distribution of the causes of jaundice
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noted that using this regime our babies responded very well to 
phototherapy with none of them requiring exchange transfusion. 
Fluid supplementation in severe hyperbilirubinemia has been well 
studied in literature. A study by Bandyopadhyay and Maiti [12] 
had shown that fluid supplementation along with DSPT in term 
neonates with severe hyperbilirubinemia significantly decreases 
the rate of exchange transfusion and duration of phototherapy. 
Another study by Goyal et al., in 2018 [13], has shown that 
50 ml/kg intravenous fluid supplementation results in faster 
decline of STB in first few hours of treatment.
Our mean duration of phototherapy was 32 h with cochlear 
implants ranging from 11 h to 53 h. This duration includes even 
those babies who had underlying hemolysis or sepsis as the cause 
of jaundice, further suggesting that breastfeeding jaundice may be 
contributing to increase in serum bilirubin levels in such babies. 
An added genetic cause for jaundice is yet another possibility in 
babies with no obvious cause and needs further research. Some 
such conditions like Gilbert syndrome need further evaluation to 
ascertain their incidence.
An important outcome noted in our study was avoidance of 
exchange transfusion by timely use of intravenous immunoglobulin 
G (IVIG) where six babies required IVIG. These babies either 
had a very high serum bilirubin or the fall in serum bilirubin 
on phototherapy was less than the recommended guidelines by 
AAP [14,15]. Further, evaluation showed that all six babies had 
an underlying cause as discussed previously. None of the babies 
showed any signs of bilirubin encephalopathy at any time of 
admission. Understanding the cumbersome process of exchange 
transfusion and the associated risks of adverse events [16], a less 
invasive strategy to decrease the rate of exchange transfusion 
should be considered. We further tried to limit the increase in 
serum bilirubin due to breakdown of excess red blood cells in 
babies with increased hematocrit in spite of hydration by partial 
exchange with normal saline. This is comparatively a safer 
procedure with less adverse effects when compared to exchange 
transfusion.
Our 1-month follow-up of 92 babies showed no clinical signs 
of neurological deficit. BERA and retinopathy of prematurity 
screening were done in babies who required IVIG/exchange 
transfusion and were found to be within normal range.
CONCLUSION
Breastfeeding jaundice should be considered as one of the common 
causes of pathological jaundice making lactational counseling 
during antenatal and postnatal period an essential component 
of management and prevention of pathological jaundice. Early 
detection and timely intervention with lesser invasive treatment 
modalities such as IVIG, hydration, and phototherapy should be 
attempted aggressively to avoid need for high-risk procedures 
like exchange transfusion.
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